{"title":"全基因组关联研究发现 IFIH1 和 HLA-DQB1*05:02 基因位点与抗 NMDAR 脑炎有关。","authors":"Xu Liu, Xiaodong Zheng, Yaqing Shu, Xiao Qu, Qun Wang, Xiao Liu, Fa-Yun Hu, Jie Liu, Yajun Lian, Bao-Ming He, Caihua Li, Dong Zhou, Wei Qiu, Liangdan Sun, Zhen Hong","doi":"10.1212/NXI.0000000000200221","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is a rare autoimmune neurologic disorder, the genetic etiology of which remains poorly understood. Our study aims to investigate the genetic basis of this disease in the Chinese Han population.</p><p><strong>Methods: </strong>We performed a genome-wide association study and fine-mapping study within the major histocompatibility complex (MHC) region of 413 Chinese patients with anti-NMDAR encephalitis recruited from 6 large tertiary hospitals and 7,127 healthy controls.</p><p><strong>Results: </strong>Our genome-wide association analysis identified a strong association at the IFIH1 locus on chromosome 2q24.2 (rs3747517, <i>p</i> = 1.06 × 10<sup>-8</sup>, OR = 1.55, 95% CI, 1.34-1.80), outside of the human leukocyte antigen (HLA) region. Furthermore, through a fine-mapping study of the MHC region, we discovered associations for 3 specific HLA class I and II alleles. Notably, HLA-DQB1*05:02 (<i>p</i> = 1.43 × 10<sup>-12</sup>; OR, 2.10; 95% CI 1.70-2.59) demonstrates the strongest association among classical HLA alleles, closely followed by HLA-A*11:01 (<i>p</i> = 4.36 × 10<sup>-7</sup>; OR, 1.52; 95% CI 1.29-1.79) and HLA-A*02:07 (<i>p</i> = 1.28 × 10<sup>-8</sup>; OR, 1.87; 95% CI 1.50-2.31). In addition, we uncovered 2 main HLA amino acid variation associated with anti-NMDAR encephalitis including HLA-DQβ1-126H (<i>p</i> = 1.43 × 10<sup>-12</sup>; OR, 2.10; 95% CI 1.70-2.59), exhibiting a predisposing effect, and HLA-B-97R (<i>p</i> = 3.40 × 10<sup>-8</sup>; OR, 0.63; 95% CI 0.53-0.74), conferring a protective effect. Computational docking analysis suggested a close relationship between the NR1 subunit of NMDAR and DQB1*05:02.</p><p><strong>Discussion: </strong>Our findings indicate that genetic variation in IFIH1, involved in the type I interferon signaling pathway and innate immunity, along with variations in the HLA class I and class II genes, has substantial implications for the susceptibility to anti-NMDAR encephalitis in the Chinese Han population.</p>","PeriodicalId":19472,"journal":{"name":"Neurology® Neuroimmunology & Neuroinflammation","volume":"11 3","pages":"e200221"},"PeriodicalIF":7.8000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11010247/pdf/","citationCount":"0","resultStr":"{\"title\":\"Genome-Wide Association Study Identifies IFIH1 and HLA-DQB1*05:02 Loci Associated With Anti-NMDAR Encephalitis.\",\"authors\":\"Xu Liu, Xiaodong Zheng, Yaqing Shu, Xiao Qu, Qun Wang, Xiao Liu, Fa-Yun Hu, Jie Liu, Yajun Lian, Bao-Ming He, Caihua Li, Dong Zhou, Wei Qiu, Liangdan Sun, Zhen Hong\",\"doi\":\"10.1212/NXI.0000000000200221\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is a rare autoimmune neurologic disorder, the genetic etiology of which remains poorly understood. Our study aims to investigate the genetic basis of this disease in the Chinese Han population.</p><p><strong>Methods: </strong>We performed a genome-wide association study and fine-mapping study within the major histocompatibility complex (MHC) region of 413 Chinese patients with anti-NMDAR encephalitis recruited from 6 large tertiary hospitals and 7,127 healthy controls.</p><p><strong>Results: </strong>Our genome-wide association analysis identified a strong association at the IFIH1 locus on chromosome 2q24.2 (rs3747517, <i>p</i> = 1.06 × 10<sup>-8</sup>, OR = 1.55, 95% CI, 1.34-1.80), outside of the human leukocyte antigen (HLA) region. Furthermore, through a fine-mapping study of the MHC region, we discovered associations for 3 specific HLA class I and II alleles. Notably, HLA-DQB1*05:02 (<i>p</i> = 1.43 × 10<sup>-12</sup>; OR, 2.10; 95% CI 1.70-2.59) demonstrates the strongest association among classical HLA alleles, closely followed by HLA-A*11:01 (<i>p</i> = 4.36 × 10<sup>-7</sup>; OR, 1.52; 95% CI 1.29-1.79) and HLA-A*02:07 (<i>p</i> = 1.28 × 10<sup>-8</sup>; OR, 1.87; 95% CI 1.50-2.31). In addition, we uncovered 2 main HLA amino acid variation associated with anti-NMDAR encephalitis including HLA-DQβ1-126H (<i>p</i> = 1.43 × 10<sup>-12</sup>; OR, 2.10; 95% CI 1.70-2.59), exhibiting a predisposing effect, and HLA-B-97R (<i>p</i> = 3.40 × 10<sup>-8</sup>; OR, 0.63; 95% CI 0.53-0.74), conferring a protective effect. Computational docking analysis suggested a close relationship between the NR1 subunit of NMDAR and DQB1*05:02.</p><p><strong>Discussion: </strong>Our findings indicate that genetic variation in IFIH1, involved in the type I interferon signaling pathway and innate immunity, along with variations in the HLA class I and class II genes, has substantial implications for the susceptibility to anti-NMDAR encephalitis in the Chinese Han population.</p>\",\"PeriodicalId\":19472,\"journal\":{\"name\":\"Neurology® Neuroimmunology & Neuroinflammation\",\"volume\":\"11 3\",\"pages\":\"e200221\"},\"PeriodicalIF\":7.8000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11010247/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurology® Neuroimmunology & Neuroinflammation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1212/NXI.0000000000200221\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/4/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology® Neuroimmunology & Neuroinflammation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1212/NXI.0000000000200221","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/5 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景和目的:抗N-甲基-d-天冬氨酸受体(NMDAR)脑炎是一种罕见的自身免疫性神经系统疾病,其遗传学病因至今仍不十分清楚。我们的研究旨在探讨该病在中国汉族人群中的遗传基础:我们对从 6 家大型三甲医院招募的 413 名中国抗 NMDAR 脑炎患者和 7127 名健康对照者进行了全基因组关联研究和主要组织相容性复合体(MHC)区域内的精细图谱研究:我们的全基因组关联分析发现,在人类白细胞抗原(HLA)区域之外的染色体2q24.2上的IFIH1位点(rs3747517,p = 1.06 × 10-8,OR = 1.55,95% CI,1.34-1.80)存在强关联。此外,通过对 MHC 区域的精细图谱研究,我们发现了 3 个特定的 HLA I 类和 II 类等位基因的相关性。值得注意的是,在经典的 HLA 等位基因中,HLA-DQB1*05:02(p = 1.43 × 10-12;OR,2.10;95% CI 1.70-2.59)显示出最强的关联性,紧随其后的是 HLA-A*11:01(p = 4.36 × 10-7;OR,1.52;95% CI 1.29-1.79)和 HLA-A*02:07(p = 1.28 × 10-8;OR,1.87;95% CI 1.50-2.31)。此外,我们还发现了两种与抗 NMDAR脑炎相关的主要 HLA 氨基酸变异,包括 HLA-DQβ1-126H (p = 1.43 × 10-12; OR, 2.10; 95% CI 1.70-2.59)和 HLA-B-97R (p = 3.40 × 10-8; OR, 0.63; 95% CI 0.53-0.74),前者具有易感作用,后者则具有保护作用。计算对接分析表明,NMDAR 的 NR1 亚基与 DQB1*05:02 关系密切:我们的研究结果表明,参与 I 型干扰素信号通路和先天性免疫的 IFIH1 基因变异以及 HLA I 类和 II 类基因变异对中国汉族人群抗 NMDAR 脑炎的易感性有重要影响。
Genome-Wide Association Study Identifies IFIH1 and HLA-DQB1*05:02 Loci Associated With Anti-NMDAR Encephalitis.
Background and objectives: Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is a rare autoimmune neurologic disorder, the genetic etiology of which remains poorly understood. Our study aims to investigate the genetic basis of this disease in the Chinese Han population.
Methods: We performed a genome-wide association study and fine-mapping study within the major histocompatibility complex (MHC) region of 413 Chinese patients with anti-NMDAR encephalitis recruited from 6 large tertiary hospitals and 7,127 healthy controls.
Results: Our genome-wide association analysis identified a strong association at the IFIH1 locus on chromosome 2q24.2 (rs3747517, p = 1.06 × 10-8, OR = 1.55, 95% CI, 1.34-1.80), outside of the human leukocyte antigen (HLA) region. Furthermore, through a fine-mapping study of the MHC region, we discovered associations for 3 specific HLA class I and II alleles. Notably, HLA-DQB1*05:02 (p = 1.43 × 10-12; OR, 2.10; 95% CI 1.70-2.59) demonstrates the strongest association among classical HLA alleles, closely followed by HLA-A*11:01 (p = 4.36 × 10-7; OR, 1.52; 95% CI 1.29-1.79) and HLA-A*02:07 (p = 1.28 × 10-8; OR, 1.87; 95% CI 1.50-2.31). In addition, we uncovered 2 main HLA amino acid variation associated with anti-NMDAR encephalitis including HLA-DQβ1-126H (p = 1.43 × 10-12; OR, 2.10; 95% CI 1.70-2.59), exhibiting a predisposing effect, and HLA-B-97R (p = 3.40 × 10-8; OR, 0.63; 95% CI 0.53-0.74), conferring a protective effect. Computational docking analysis suggested a close relationship between the NR1 subunit of NMDAR and DQB1*05:02.
Discussion: Our findings indicate that genetic variation in IFIH1, involved in the type I interferon signaling pathway and innate immunity, along with variations in the HLA class I and class II genes, has substantial implications for the susceptibility to anti-NMDAR encephalitis in the Chinese Han population.
期刊介绍:
Neurology Neuroimmunology & Neuroinflammation is an official journal of the American Academy of Neurology. Neurology: Neuroimmunology & Neuroinflammation will be the premier peer-reviewed journal in neuroimmunology and neuroinflammation. This journal publishes rigorously peer-reviewed open-access reports of original research and in-depth reviews of topics in neuroimmunology & neuroinflammation, affecting the full range of neurologic diseases including (but not limited to) Alzheimer's disease, Parkinson's disease, ALS, tauopathy, and stroke; multiple sclerosis and NMO; inflammatory peripheral nerve and muscle disease, Guillain-Barré and myasthenia gravis; nervous system infection; paraneoplastic syndromes, noninfectious encephalitides and other antibody-mediated disorders; and psychiatric and neurodevelopmental disorders. Clinical trials, instructive case reports, and small case series will also be featured.